Literature DB >> 11276328

How common is hearing impairment in osteogenesis imperfecta?

C R Paterson1, E A Monk, S J McAllion.   

Abstract

Hearing impairment has long been recognized as a common feature in osteogenesis imperfecta. The figures in some publications could be taken to imply that, with increasing age, the proportion of osteogenesis imperfecta patients with hearing impairment approaches 100 per cent. The incidence of hearing loss in a large survey of 1394 patients with osteogenesis imperfecta was examined. It was found that the most common age of onset was in the second, third and fourth decades of life. At the age of 50 approximately 50 per cent of the patients had symptoms of hearing impairment; over the next 20 years there was little further increase. Differences were shown between patients with different clinical types of osteogenesis imperfecta as delineated in the Sillence classification; hearing loss was significantly less common in the type IV disease than in the type I disorder. Among the 29 families with osteogenesis imperfecta type IA there were distinct differences in the likelihood of hearing loss. These findings provide insights which will be valuable in giving patients advice on the likelihood of developing hearing loss in the future.

Entities:  

Mesh:

Year:  2001        PMID: 11276328     DOI: 10.1258/0022215011907442

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  9 in total

Review 1.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

2.  Osteogenesis imperfecta and hearing loss: an analysis of patients attended at a benchmark treatment center in southern Brazil.

Authors:  Andressa Colares da Costa Otavio; Adriane Ribeiro Teixeira; Temis Maria Félix; Letícia Petersen Schimidt Rosito; Sady Selaimen da Costa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-31       Impact factor: 2.503

Review 3.  Advances in the Classification and Treatment of Osteogenesis Imperfecta.

Authors:  Inas H Thomas; Linda A DiMeglio
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

4.  Osteogenesis imperfecta: a case with hand deformities.

Authors:  Bengi Oz; Nese Olmez; Asuman Memis
Journal:  Clin Rheumatol       Date:  2005-04-23       Impact factor: 2.980

5.  Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults.

Authors:  J D Hald; L Folkestad; C Z Swan; J Wanscher; M Schmidt; H Gjørup; D Haubek; C-H Leonhard; D A Larsen; J Ø Hjortdal; T Harsløf; M Duno; A M Lund; J-E B Jensen; K Brixen; B Langdahl
Journal:  Osteoporos Int       Date:  2018-08-24       Impact factor: 4.507

6.  Prolyl 3-hydroxylase-1 null mice exhibit hearing impairment and abnormal morphology of the middle ear bone joints.

Authors:  Elena Pokidysheva; Sara Tufa; Chris Bresee; John V Brigande; Hans Peter Bächinger
Journal:  Matrix Biol       Date:  2012-11-24       Impact factor: 11.583

7.  Osteogenesis Imperfecta: the audiological phenotype lacks correlation with the genotype.

Authors:  Freya K R Swinnen; Paul J Coucke; Anne M De Paepe; Sofie Symoens; Fransiska Malfait; Filomena V Gentile; Luca Sangiorgi; Patrizia D'Eufemia; Mauro Celli; Ton J T M Garretsen; Cor W R J Cremers; Ingeborg J M Dhooge; Els M R De Leenheer
Journal:  Orphanet J Rare Dis       Date:  2011-12-29       Impact factor: 4.123

8.  Osteogenesis Imperfecta with Celiac Disease and Type II Diabetes Mellitus Associated: Improvement with a Gluten-Free Diet.

Authors:  Luis Rodrigo; Isabel Pérez-Martinez
Journal:  Case Rep Med       Date:  2012-03-05

9.  High Heterogeneity of Temporal Bone CT Aspects in Osteogenesis Imperfecta Is Not Linked to Hearing Loss.

Authors:  Aïcha Ltaief-Boudrigua; Genevieve Lina-Granade; Eric Truy; Ruben Hermann; Guillaume Chevrel
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.